Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05212025
Title Adavosertib and Gemcitabine in Advanced Pancreatic
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors James Cleary, MD, PhD
Indications

pancreatic adenocarcinoma

Therapies

Adavosertib + Gemcitabine

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field